Brevan Howard Capital Management LP lifted its position in Carter’s, Inc. (NYSE:CRI – Free Report) by 41.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 35,895 shares of the textile maker’s stock after acquiring an additional 10,508 shares during the quarter. Brevan Howard Capital Management LP owned 0.10% of Carter’s worth $1,945,000 as of its most recent SEC filing.
Other hedge funds also recently added to or reduced their stakes in the company. Barclays PLC raised its holdings in shares of Carter’s by 58.7% in the 3rd quarter. Barclays PLC now owns 20,077 shares of the textile maker’s stock valued at $1,304,000 after purchasing an additional 7,429 shares in the last quarter. Franklin Resources Inc. increased its holdings in Carter’s by 109.8% during the third quarter. Franklin Resources Inc. now owns 38,617 shares of the textile maker’s stock valued at $2,468,000 after buying an additional 20,210 shares during the period. GAMMA Investing LLC raised its stake in Carter’s by 258.0% in the fourth quarter. GAMMA Investing LLC now owns 1,450 shares of the textile maker’s stock worth $79,000 after buying an additional 1,045 shares in the last quarter. Pallas Capital Advisors LLC increased its holdings in shares of Carter’s by 66.7% in the 4th quarter. Pallas Capital Advisors LLC now owns 5,182 shares of the textile maker’s stock valued at $281,000 after acquiring an additional 2,074 shares during the period. Finally, Oak Thistle LLC bought a new position in shares of Carter’s in the 4th quarter worth $410,000.
Carter’s Price Performance
Shares of CRI stock opened at $32.79 on Wednesday. Carter’s, Inc. has a fifty-two week low of $32.04 and a fifty-two week high of $72.11. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.96 and a current ratio of 2.21. The firm has a market capitalization of $1.19 billion, a price-to-earnings ratio of 5.20, a PEG ratio of 3.37 and a beta of 1.05. The stock’s 50-day simple moving average is $38.28 and its 200-day simple moving average is $48.50.
Carter’s Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, March 28th. Investors of record on Monday, March 10th were paid a $0.80 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $3.20 dividend on an annualized basis and a yield of 9.76%. Carter’s’s dividend payout ratio (DPR) is 70.80%.
Wall Street Analyst Weigh In
A number of equities research analysts recently weighed in on CRI shares. UBS Group dropped their price objective on Carter’s from $37.00 to $32.00 and set a “neutral” rating on the stock in a research report on Monday, April 28th. Wells Fargo & Company cut shares of Carter’s from an “equal weight” rating to an “underweight” rating and lowered their price target for the company from $40.00 to $25.00 in a report on Wednesday, April 30th. Citigroup reduced their price objective on shares of Carter’s from $50.00 to $45.00 and set a “neutral” rating for the company in a research note on Wednesday, February 26th. Finally, Barclays initiated coverage on shares of Carter’s in a research note on Monday, April 28th. They issued an “underweight” rating and a $25.00 target price for the company. Three equities research analysts have rated the stock with a sell rating and two have given a hold rating to the stock. According to data from MarketBeat, Carter’s currently has a consensus rating of “Reduce” and an average target price of $36.20.
View Our Latest Analysis on CRI
Carter’s Profile
Carter’s, Inc engages in the business of brand marketing of young children’s apparel. It operates through the following segments: the United States (US) Retail, US Wholesale, and International. The US Retail segment includes selling products through retail stores and ecommerce websites. The US Wholesale segment focuses on wholesale partners.
Further Reading
- Five stocks we like better than Carter’s
- Buy P&G Now, Before It Sets A New All-Time High
- 3 Mid-Cap Medical Stocks Outperforming the Market
- How to Buy Cheap Stocks Step by Step
- The Top-Ranked Insider Buys From April by Market Cap
- What is an Earnings Surprise?
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
Want to see what other hedge funds are holding CRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Carter’s, Inc. (NYSE:CRI – Free Report).
Receive News & Ratings for Carter's Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carter's and related companies with MarketBeat.com's FREE daily email newsletter.